# New cancer clinical trials, last 30 days: 425 (2026)

Updated November 19, 2026.

425 new trials for cancer were first posted on ClinicalTrials.gov in the 30 days from October 20, 2026 to November 18, 2026, as read on November 19, 2026.

## The full list

New cancer clinical trials, last 30 days: 425 rows for $21.25, first posted from October 20, 2026 to November 18, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 61 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/new/neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 425
- Recruiting or not yet: 357
- Read on: November 19, 2026

## Trials

The 25 newest of 425, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07947134 | A Study of GSK5864399 Administered Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumours | GlaxoSmithKline | Phase 1/2 | Not yet recruiting | Solid Tumours | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947134) |
| November 18, 2026 | NCT07947121 | A Study of Risvutatug Rezetecan in Combination With Atezolizumab in Participants With Extensive Stage Small Cell Lung Cancer... | GlaxoSmithKline | Phase 3 | Not yet recruiting | Lung Neoplasm | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947121) |
| November 18, 2026 | NCT07947043 | Exploratory Clinical Study of Autologous Tumor-Infiltrating Lymphocytes (TIL) Injection | Tongji Hospital | Phase 1 | Recruiting | Recurrent or Metastatic Lung Cancer or Cervical Cancer | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07947043) |
| November 18, 2026 | NCT07946965 | A Prospective External Control Arm Study in Colorectal Cancer | N-Power Medicine | Observational | Not yet recruiting | Colorectal Cancer | 650 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946965) |
| November 18, 2026 | NCT07946848 | Phase 2 Study to Evaluate Dose Optimization and Anti-tumor Activity of Atebimetinib in Participants With Advanced or Metastatic NSCLC. | Immuneering Corporation | Phase 2 | Not yet recruiting | NSCLC (Advanced Non-small Cell Lung Cancer), Non-Squamous Non Small Cell Lung Cancer, Metastatic Non-Small Lung Cell... | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946848) |
| November 18, 2026 | NCT07946445 | Assessment of Patient Radiation Exposure and Development of Diagnostic Reference Levels(DRLs) Standards for Endoscopic Retrograde... | Institute of Liver and Biliary Sciences, India | Observational | Not yet recruiting | Choledocholithiasis, Biliary Stricture, Chronic Pancreatitis, Periampullary Carcinoma, Cholangiocar.... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946445) |
| November 18, 2026 | NCT07946393 | Preoperative CA 19-9 and the Pattern and Timing of Recurrence After Pancreatoduodenectomy (Whipple Operation) for Pancreatic Cancer | Minia University | Observational | Not yet recruiting | Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946393) |
| November 18, 2026 | NCT07946380 | Mesopancreas Excision in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma | Minia University | Not applicable | Not yet recruiting | Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasms, Pancreatic Head Cancer | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946380) |
| November 18, 2026 | NCT07946224 | Comparison of Breast Acoustic CT and Automated Breast Ultrasound in Women With Unilateral Untreated Breast Cancer | Stanford University | Not applicable | Not yet recruiting | Breast Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07946224) |
| November 18, 2026 | NCT07945821 | A Study of Tagmokitug in Combination With Other Treatments in Participants With Advanced or Metastatic Solid Tumors | Coherus Oncology, Inc. | Phase 1/2 | Recruiting | Solid Tumor | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945821) |
| November 18, 2026 | NCT07945756 | Development of a Gastric Cancer Screening Intervention for H. Pylori Carriers Based on the Health Belief Model | Chinese University of Hong Kong | Not applicable | Not yet recruiting | Gastric Cancer (GC) | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945756) |
| November 18, 2026 | NCT07945548 | A Study Characterizing the Elevated Liver Enzymes in Ribociclib Treated HR+ HER2- Advanced Breast Cancer Patients Using a Machine Learning... | Novartis Pharmaceuticals | Observational | Not yet recruiting | Breast Cancer | 8,001 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945548) |
| November 18, 2026 | NCT07944924 | Endoscopic Ultrasound Predictors of Malignancy in IPMNs: Toward Personalized, Data-driven Risk Stratification | IRCCS San Raffaele | Observational | Completed | Intraductal Papillary Mucinous Neoplasms, Pancreatic Cystic Neoplasms, IPMN, Pancreatic Neoplasms, Pancreatic Cancer | 198 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944924) |
| November 18, 2026 | NCT07944664 | A Phase 4, Single-arm, Interventional Study to Evaluate the Safety and Tolerability of Zolbetuximab Plus SOX as First-line Treatment of... | Sponsor not shown (see the record) | Phase 4 | Active not recruiting | Gastric Cancer (GC), Gastroesophageal Junction (GEJ) Adenocarcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944664) |
| November 18, 2026 | NCT07944469 | Cryoablation Versus Standard Nerve Block for Pain Control After Lung Surgery | University Medical Centre Maribor | Not applicable | Enrolling by invitation | Postoperative Pain After Thoracic Surgery, Lung Cancer (Suspected or Confirmed) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944469) |
| November 18, 2026 | NCT07944235 | Preoperative and Postoperative Radiosurgery in Patients With Brain Metastases Undergoing Surgery | Fundacion Miguel Servet | Not applicable | Recruiting | Brain Neoplasms, Neoplasm Metastasis, Radiosurgery, Neoadjuvant Therapy, Radiotherapy Adjuvant, Surgery | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944235) |
| November 18, 2026 | NCT07944144 | A Phase I/II Study to Learn About the Safety and Effects of a New Medicine Called IPN60350 Alone or in Combination With Other Anticancer... | Ipsen | Phase 1/2 | Not yet recruiting | Neoplasms, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944144) |
| November 17, 2026 | NCT07943533 | HLX22 Combination Therapy in HER2-Positive Limited Metastatic Gastric Cancer | Shanghai Zhongshan Hospital | Phase 2 | Not yet recruiting | HER2-Positive, Limited Metastatic, Gastric Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943533) |
| November 17, 2026 | NCT07943494 | Multimodal LLM for Breast Cancer Radiotherapy Target Auto-Contouring and Planning | Sponsor not shown (see the record) | Observational | Not yet recruiting | Breast Cancer, Radiotherapy | 51,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943494) |
| November 17, 2026 | NCT07943078 | A Study of JNJ-99220732 in Participants With Advanced or Metastatic Solid Tumors | Janssen Research & Development, LLC | Phase 1 | Not yet recruiting | Neoplasms | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943078) |
| November 17, 2026 | NCT07943039 | Safety and Efficacy of pALG in Conditioning Regimen for HLA-Matched Sibling HSCT in Patients With SAA or Hematological Malignancies (... | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Severe Aplastic Anemia (SAA), Hematologic Malignancies | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943039) |
| November 17, 2026 | NCT07942961 | Evaluation of a Values-Clarification Tool for Older Adults With Cancer | UNC Lineberger Comprehensive Cancer Center | Not applicable | Completed | Cancer, Malignancy | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942961) |
| November 17, 2026 | NCT07942909 | Action For Better Health After Cancer | University of Liege | Not applicable | Completed | Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942909) |
| November 17, 2026 | NCT07942558 | An Investigation of Fear of Progression Among Cancer Patients | University of Bordeaux | Observational | Recruiting | Cancer | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942558) |
| November 17, 2026 | NCT07942506 | The Effect of Health Education Conducted Using Two Different Methods on Individuals in a High-risk Age Group Regarding Their Health Beliefs... | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | Not applicable | Completed | Colorectal Cancer Screening | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942506) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 3 |
| Phase 1 | 31 |
| Phase 1/2 | 16 |
| Phase 2 | 82 |
| Phase 2/3 | 4 |
| Phase 3 | 18 |
| Phase 4 | 4 |
| Not applicable | 151 |
| Observational | 116 |

## Sponsors posting most

| Sponsor | Trials |
| --- | --- |
| Ruijin Hospital | 8 |
| UNC Lineberger Comprehensive Cancer Center | 6 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 6 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 6 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 6 |
| Sir Run Run Shaw Hospital | 5 |
| Fudan University | 5 |
| Memorial Sloan Kettering Cancer Center | 5 |
| Assiut University | 5 |
| Masaryk Memorial Cancer Institute | 4 |
| Beijing Tsinghua Chang Gung Hospital | 4 |
| IRCCS San Raffaele | 3 |
| Wake Forest University Health Sciences | 3 |
| Mahidol University | 3 |
| Royal Marsden NHS Foundation Trust | 3 |
| National Cancer Institute (NCI) | 3 |
| Xiangya Hospital of Central South University | 3 |
| Washington University School of Medicine | 3 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 3 |
| The First Affiliated Hospital with Nanjing Medical University | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 3 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 2 |
| Tongji Hospital | 2 |
| Minia University | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Career counseling services in the United States](https://specstream.ai/data/businesses/career-counseling-services/united-states)
- [Radiology practices in the United States](https://specstream.ai/data/businesses/radiology-practices/united-states)
- [Family practice clinics in the United States](https://specstream.ai/data/businesses/family-practice-clinics/united-states)
- [Vehicle shipping companies in the United States](https://specstream.ai/data/businesses/vehicle-shipping-companies/united-states)
- [Kitchen supply stores in the United States](https://specstream.ai/data/businesses/kitchen-supply-stores/united-states)
- [Beer bars in the United States](https://specstream.ai/data/businesses/beer-bars/united-states)
